Deep-learning Predictors of Abdominal Aortic Aneurysm Enlargement in Type II Endoleaks After Endovascular Aortic Repair: The RADAR Study
NCT07783126 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1250
Last updated 2026-08-24
Summary
Background and rationale:
Abdominal aortic aneurysm (AAA) is a weakening and enlargement of the main artery in the abdomen. Endovascular aneurysm repair (EVAR) is a minimally invasive treatment used to repair an AAA. After EVAR, some patients develop a complication, called a type II endoleak (T2EL), in which blood continues to flow into the aneurysm sac through small blood vessels. Many T2ELs disappear on their own, but in some patients they can cause the aneurysm sac to enlarge and may require another procedure. The RADAR study aims to develop a deep-learning computer model that can use the CT scan performed before EVAR to predict which patients are more likely to develop a T2EL associated with aneurysm enlargement. The model will be developed using information from several hospitals and tested on patients from hospitals that were not involved in its development.
Duration: July 2026 - December 2028
The study will include patients who have undergone EVAR between 1 January 2015 and 31 December 2025. Their available follow-up information will be collected until 31 December 2026 or until an earlier event such as the last available CT scan, a procedure related to T2EL, another defined medical event, or death. The baseline postoperative CTA, acquired 1-3 months after EVAR, will serve as the reference examination for assessment of aneurysm-sac growth during follow-up. Patients who have not developed the study outcome generally need at least 24 months of imaging follow-up to be classified reliably.
Objectives:
The primary objective is to develop and test a deep-learning model that can predict, before EVAR, whether a patient will develop a T2EL and whether it will be associated with significant enlargement of the aneurysm sac. The model will be tested using data from hospitals that were not involved in its development. Secondary objectives are to assess whether the model works consistently across different hospitals and CT scanning methods; compare the new model with the original NornirNet model; determine whether adding clinical and anatomical information improves the predictions; assess differences in performance between hospitals; and evaluate how well the model's predicted risks correspond to the outcomes actually observed.
Study population:
The study is a multicenter observational study involving patients over the age of 18 who underwent elective EVAR for an intact fusiform abdominal aortic aneurysm at participating hospitals in Switzerland, Europe, and the United States between 2015 and 2025. Patients must have suitable CT scans before and after EVAR and sufficient medical and imaging information to determine whether a T2EL occurred and how the aneurysm changed over time. Patients treated for a ruptured aneurysm, patients with certain other types of aneurysms, patients who had previous aortic procedures, and patients whose CT scans are not suitable for analysis will be excluded. The planned study population is approximately 1,250 patients, depending on the number of eligible patients available at the participating hospitals.
Study procedures:
This is a retrospective study, meaning that it uses information and CT scans that were already collected as part of routine medical care. No additional examinations or procedures are performed for the study, and no biological samples are collected. Participating hospitals will provide coded clinical information and anonymized CT scans. The information collected may include age, sex, other medical conditions, body weight and height, laboratory results, heart-related information, details about the aneurysm and blood vessels, and information about the EVAR procedure. Follow-up CT scans will be reviewed by specialists to determine whether a T2EL occurred and whether the aneurysm sac became larger. Patients will be classified into three groups: those with no T2EL, those with a T2EL without significant aneurysm enlargement, and those with a T2EL associated with aneurysm enlargement of at least 5 mm or a related additional procedure. The deep-learning model will be developed using data from some participating hospitals and then tested on data from other hospitals that were not involved in developing the model. Its ability to make accurate and consistent predictions will then be evaluated.
Conditions
- Type II Endoleak
- Abdominal Aortic Aneurysm Enlargement
Interventions
- OTHER
-
Artificial intelligence model analyzing preoperative CT angiography
This study involves the retrospective multicenter analysis of preoperative CT angiography (CTA) and clinical data from patients who underwent EVAR. A new and improved three-dimensional deep-learning model, building on the NornirNet framework, will be developed using data from designated development centers and subsequently evaluated, after model freezing, on independent held-out centers.
Sponsors & Collaborators
-
Ente Ospedaliero Cantonale, Bellinzona
lead OTHER
Principal Investigators
-
Giorgio Prouse, MD · Ente Ospedaliero Cantonale, Bellinzona
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-10-01
- Primary Completion
- 2027-12-31
- Completion
- 2028-12-31
More Related Trials
-
Adjuvant Radiation in Aortic Valvuloplasty - ARAVA
NCT00269165 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Lipid Metabolism and Mitochondrial Function in Myeloid Cells and Total Aortic Tissue in Patients With Ascending Thoracic Aortic Aneurysm (ATA) and Bicuspid (BA) or Tricuspid (TA) Aortic Valves.
NCT07695545 ·Status: RECRUITING
-
Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography
NCT02213666 ·Status: COMPLETED
-
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
NCT07308704 ·Status: RECRUITING
-
Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study
NCT06749132 ·Status: ENROLLING_BY_INVITATION
-
An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.
NCT07062848 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
NCT02260466 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of New Predictors and Short Term Outcomes of Paravalvular Leakage After Transcatheter Aortic Valve Implanation
NCT03424902 ·Status: UNKNOWN
-
Artificial Intelligence to Scale Early Rheumatic Heart Disease Detection
NCT07599956 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis
NCT02825134 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography
NCT02073617 ·Status: COMPLETED ·Phase: NA
-
Neurocognitive Assessment in TAVI
NCT06120946 ·Status: COMPLETED
-
Assessments of Thrombus Formation in TAVI
NCT03248232 ·Status: COMPLETED
-
Digital Twin and Ml-basEd MOdel of TEVAR Interventions
NCT07640828 ·Status: RECRUITING
-
Outcomes of Aortic Dissection Repair
NCT05927090 ·Status: ENROLLING_BY_INVITATION
-
Assessment of the Prognosis of Persistent Left Bundle Branch Block (LBBB)After Transcatheter Aortic Valve Implantation (TAVI ) by an Electrophysiological and Remote Monitoring Risk-adapted Algorithm
NCT02482844 ·Status: UNKNOWN ·Phase: PHASE4
-
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899 ·Status: COMPLETED ·Phase: NA
-
Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis
NCT00538759 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
AI-based Echocardiography for Detection of Cardiac Amyloidosis
NCT07529860 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Neurologic Injury Subsequent to Transcatheter Aortic Valve Replacement: A Feasibility Study
NCT01927601 ·Status: WITHDRAWN
-
ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers
NCT07314268 ·Status: RECRUITING
-
Outcome Prediction in Patients With Aortic Stenosis After TAVI
NCT06043180 ·Status: NOT_YET_RECRUITING
-
ATTR Amyloidosis in Elderly Patients With Aortic Stenosis
NCT04061213 ·Status: UNKNOWN
-
Smartphone Based Digital Screening for Aortic Valve Stenosis
NCT07284550 ·Status: RECRUITING
-
A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).
NCT06029452 ·Status: COMPLETED